- Application under evaluation
- CVMP opinion
- European Commission decision
Overview
The marketing authorisation for Netvax has been withdrawn at the request of the marketing authorisation holder.
Netvax : EPAR - Summary for the public
English (EN) (494.17 KB - PDF)
български (BG) (691.18 KB - PDF)
español (ES) (513.14 KB - PDF)
čeština (CS) (657.18 KB - PDF)
dansk (DA) (495.53 KB - PDF)
Deutsch (DE) (497.85 KB - PDF)
eesti keel (ET) (511.72 KB - PDF)
ελληνικά (EL) (691.94 KB - PDF)
français (FR) (496.07 KB - PDF)
italiano (IT) (495.88 KB - PDF)
latviešu valoda (LV) (665.3 KB - PDF)
lietuvių kalba (LT) (632.52 KB - PDF)
magyar (HU) (632.48 KB - PDF)
Malti (MT) (661.22 KB - PDF)
Nederlands (NL) (495.23 KB - PDF)
polski (PL) (652.17 KB - PDF)
português (PT) (512.51 KB - PDF)
română (RO) (610.38 KB - PDF)
slovenčina (SK) (656.59 KB - PDF)
slovenščina (SL) (646.29 KB - PDF)
Suomi (FI) (512.09 KB - PDF)
svenska (SV) (494.45 KB - PDF)
Product information
Netvax : EPAR - Product Information
English (EN) (630.31 KB - PDF)
български (BG) (1.53 MB - PDF)
español (ES) (644.06 KB - PDF)
čeština (CS) (879.61 KB - PDF)
dansk (DA) (638.6 KB - PDF)
Deutsch (DE) (643.82 KB - PDF)
eesti keel (ET) (634.66 KB - PDF)
ελληνικά (EL) (1014.48 KB - PDF)
français (FR) (640.93 KB - PDF)
íslenska (IS) (647.66 KB - PDF)
italiano (IT) (636.47 KB - PDF)
latviešu valoda (LV) (892.65 KB - PDF)
lietuvių kalba (LT) (637.98 KB - PDF)
magyar (HU) (865.89 KB - PDF)
Malti (MT) (891.49 KB - PDF)
Nederlands (NL) (628.55 KB - PDF)
norsk (NO) (631.53 KB - PDF)
polski (PL) (859.67 KB - PDF)
português (PT) (636.23 KB - PDF)
română (RO) (641.64 KB - PDF)
slovenčina (SK) (858.29 KB - PDF)
slovenščina (SL) (855.5 KB - PDF)
Suomi (FI) (633.63 KB - PDF)
svenska (SV) (636.09 KB - PDF)
Netvax : EPAR - All Authorised presentations
English (EN) (510.63 KB - PDF)
български (BG) (526.17 KB - PDF)
español (ES) (505.35 KB - PDF)
čeština (CS) (523.19 KB - PDF)
dansk (DA) (509.13 KB - PDF)
Deutsch (DE) (519.36 KB - PDF)
eesti keel (ET) (508.5 KB - PDF)
ελληνικά (EL) (524.31 KB - PDF)
français (FR) (506.38 KB - PDF)
íslenska (IS) (503.46 KB - PDF)
italiano (IT) (506.08 KB - PDF)
latviešu valoda (LV) (523.1 KB - PDF)
lietuvių kalba (LT) (510.11 KB - PDF)
magyar (HU) (522.92 KB - PDF)
Malti (MT) (537.03 KB - PDF)
Nederlands (NL) (509.48 KB - PDF)
norsk (NO) (501.02 KB - PDF)
polski (PL) (524.71 KB - PDF)
português (PT) (507.63 KB - PDF)
română (RO) (507.21 KB - PDF)
slovenčina (SK) (523.3 KB - PDF)
slovenščina (SL) (519.18 KB - PDF)
Suomi (FI) (506.63 KB - PDF)
svenska (SV) (510.88 KB - PDF)
Product details
- Name of medicine
- Netvax
- Active substance
- Clostridium-perfringens-type-A alpha toxoid
- International non-proprietary name (INN) or common name
- adjuvanted vaccine against necrotic enteritis of chickens due to Clostridium perfringens
- Species
- Chicken
- Anatomical therapeutic chemical veterinary (ATCvet) code
- QI01AB08
Pharmacotherapeutic group
Immunologicals for avesTherapeutic indication
For the active immunisation of chickens to provide passive immunisation against necrotic enteritis to their progeny, during the laying period.
To reduce mortality and the incidence and severity of lesions caused by Clostridium-perfringens-type-A-induced necrotic enteritis. Efficacy was demonstrated by challenge of chicks approximately three weeks after hatching.
The onset of passive transfer of immunity: 6 weeks following completion of the vaccination procedure.
The duration of passive transfer of immunity: 51 weeks following completion of the vaccination procedure.
Authorisation details
- EMA product number
- EMEA/V/C/000134
- Marketing authorisation holder
- Intervet International BV
Wim de Körverstraat 35
5831 AN Boxmeer
The Netherlands - Marketing authorisation issued
- 16/04/2009
- Revision
- 2
Assessment history
Netvax : EPAR - Procedural steps taken and scientific information after authorisation
English (EN) (525.68 KB - PDF)
Netvax : EPAR - Scientific Discussion
English (EN) (849.61 KB - PDF)
Netvax : EPAR - Procedural steps taken before authorisation
English (EN) (539.57 KB - PDF)
Committee for medicinal products for veterinary use summary of opinion: Netvax: Clostridium perfringens type A toxoid
English (EN) (474.12 KB - PDF)